Literature DB >> 31828413

Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection.

Bettina Baessler1,2, Tim Nestler3, Daniel Pinto Dos Santos4, Pia Paffenholz3, Vikram Zeuch5, David Pfister3, David Maintz4, Axel Heidenreich3.   

Abstract

OBJECTIVES: To evaluate whether a computed tomography (CT) radiomics-based machine learning classifier can predict histopathology of lymph nodes (LNs) after post-chemotherapy LN dissection (pcRPLND) in patients with metastatic non-seminomatous testicular germ cell tumors (NSTGCTs).
METHODS: Eighty patients with retroperitoneal LN metastases and contrast-enhanced CT were included into this retrospective study. Resected LNs were histopathologically classified into "benign" (necrosis/fibrosis) or "malignant" (viable tumor/teratoma). On CT imaging, 204 corresponding LNs were segmented and 97 radiomic features per LN were extracted after standardized image processing. The dataset was split into training, test, and validation sets. After stepwise feature reduction based on reproducibility, variable importance, and correlation analyses, a gradient-boosted tree was trained and tuned on the selected most important features using the training and test datasets. Model validation was performed on the independent validation dataset.
RESULTS: The trained machine learning classifier achieved a classification accuracy of 0.81 in the validation dataset with a misclassification of 8 of 36 benign LNs as malignant and 4 of 25 malignant LNs as benign (sensitivity 88%, specificity 72%, negative predictive value 88%). In contrast, a model containing only the LN volume resulted in a classification accuracy of 0.68 with 64% sensitivity and 68% specificity.
CONCLUSIONS: CT radiomics represents an exciting new tool for improved prediction of the presence of malignant histopathology in retroperitoneal LN metastases from NSTGCTs, aiming at reducing overtreatment in this group of young patients. Thus, the presented approach should be combined with established clinical biomarkers and further validated in larger, prospective clinical trials. KEY POINTS: • Patients with metastatic non-seminomatous testicular germ cell tumors undergoing post-chemotherapy retroperitoneal lymph node dissection of residual lesions show overtreatment in up to 50%. • We assessed whether a CT radiomics-based machine learning classifier can predict histopathology of lymph nodes after post-chemotherapy lymph node dissection. • The trained machine learning classifier achieved a classification accuracy of 0.81 in the validation dataset with a sensitivity of 88% and a specificity of 78%, thus allowing for prediction of the presence of viable tumor or teratoma in retroperitoneal lymph node metastases.

Entities:  

Keywords:  Lymph nodes; Testicular neoplasms; Tomography

Mesh:

Year:  2019        PMID: 31828413     DOI: 10.1007/s00330-019-06495-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

Authors:  Ricardo Leão; Madhur Nayan; Nahid Punjani; Michael A S Jewett; Kamel Fadaak; Juan Garisto; Jeremy Lewin; Eshetu G Atenafu; Joan Sweet; Lynn Anson-Cartwright; Peter Boström; Peter Chung; Padraig Warde; Philippe L Bedard; Aditya Bagrodia; Yuval Freifeld; Nicholas Power; Eric Winquist; Robert J Hamilton
Journal:  Eur Urol Focus       Date:  2018-02-07

2.  Surgical management and outcomes of patients with bone metastases in germ cell tumors: A case series.

Authors:  Alessandro Nini; Marcus Konieczny; Christian Winter; Achim Lusch; Rüdiger Krauspe; Peter Albers
Journal:  Urol Oncol       Date:  2017-11-10       Impact factor: 3.498

3.  Subacute and Chronic Left Ventricular Myocardial Scar: Accuracy of Texture Analysis on Nonenhanced Cine MR Images.

Authors:  Bettina Baessler; Manoj Mannil; Sabrina Oebel; David Maintz; Hatem Alkadhi; Robert Manka
Journal:  Radiology       Date:  2017-08-23       Impact factor: 11.105

4.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.

Authors:  Shaoxu Wu; Junjiong Zheng; Yong Li; Hao Yu; Siya Shi; Weibin Xie; Hao Liu; Yangfan Su; Jian Huang; Tianxin Lin
Journal:  Clin Cancer Res       Date:  2017-09-05       Impact factor: 12.531

5.  Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours.

Authors:  A Heidenreich; F Haidl; P Paffenholz; Ch Pape; U Neumann; D Pfister
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

6.  Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA).

Authors:  O Klepp; P Flodgren; H Maartman-Moe; C E Lindholm; B Unsgaard; H Teigum; S D Fosså; E Paus
Journal:  Ann Oncol       Date:  1990-07       Impact factor: 32.976

7.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.

Authors:  Yan-Qi Huang; Chang-Hong Liang; Lan He; Jie Tian; Cui-Shan Liang; Xin Chen; Ze-Lan Ma; Zai-Yi Liu
Journal:  J Clin Oncol       Date:  2016-05-02       Impact factor: 44.544

8.  Predicting the Future - Big Data, Machine Learning, and Clinical Medicine.

Authors:  Ziad Obermeyer; Ezekiel J Emanuel
Journal:  N Engl J Med       Date:  2016-09-29       Impact factor: 91.245

9.  [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.

Authors:  Karin Oechsle; Michael Hartmann; Winfried Brenner; Stephan Venz; Lothar Weissbach; Christiane Franzius; Sabine Kliesch; Stephan Mueller; Susanne Krege; Ruediger Heicappell; Roland Bares; Carsten Bokemeyer; Maike de Wit
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

10.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

View more
  15 in total

Review 1.  Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study.

Authors:  Milap Shah; Nithesh Naik; Bhaskar K Somani; B M Zeeshan Hameed
Journal:  Turk J Urol       Date:  2020-05-27

2.  Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).

Authors:  Alessandro Nini; Matthias Boschheidgen; Andreas Hiester; Christian Winter; Gerald Antoch; Lars Schimmöller; Peter Albers
Journal:  World J Urol       Date:  2021-11-03       Impact factor: 4.226

3.  Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic review.

Authors:  Friedemann Zengerling; Dirk Beyersdorff; Jonas Busch; Julia Heinzelbecker; David Pfister; Christian Ruf; Christian Winter; Peter Albers; Sabine Kliesch; Stefanie Schmidt
Journal:  World J Urol       Date:  2022-07-29       Impact factor: 3.661

Review 4.  Challenges in ensuring the generalizability of image quantitation methods for MRI.

Authors:  Kathryn E Keenan; Jana G Delfino; Kalina V Jordanova; Megan E Poorman; Prathyush Chirra; Akshay S Chaudhari; Bettina Baessler; Jessica Winfield; Satish E Viswanath; Nandita M deSouza
Journal:  Med Phys       Date:  2021-09-29       Impact factor: 4.506

Review 5.  Artificial Intelligence Applications in Urology: Reporting Standards to Achieve Fluency for Urologists.

Authors:  Andrew B Chen; Taseen Haque; Sidney Roberts; Sirisha Rambhatla; Giovanni Cacciamani; Prokar Dasgupta; Andrew J Hung
Journal:  Urol Clin North Am       Date:  2021-10-23       Impact factor: 2.766

6.  The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens.

Authors:  Lara Kremer; Melanie von Brandenstein; Maike Wittersheim; Barbara Koeditz; Pia Paffenholz; Martin Hellmich; David Pfister; Axel Heidenreich; Tim Nestler
Journal:  Transl Androl Urol       Date:  2021-04

7.  Artificial intelligence performance in detecting tumor metastasis from medical radiology imaging: A systematic review and meta-analysis.

Authors:  Qiuhan Zheng; Le Yang; Bin Zeng; Jiahao Li; Kaixin Guo; Yujie Liang; Guiqing Liao
Journal:  EClinicalMedicine       Date:  2020-12-25

8.  Amide proton transfer weighted (APTw) imaging based radiomics allows for the differentiation of gliomas from metastases.

Authors:  Elisabeth Sartoretti; Thomas Sartoretti; Michael Wyss; Carolin Reischauer; Luuk van Smoorenburg; Christoph A Binkert; Sabine Sartoretti-Schefer; Manoj Mannil
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

9.  Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.

Authors:  Yuto Sugai; Noriyuki Kadoya; Shohei Tanaka; Shunpei Tanabe; Mariko Umeda; Takaya Yamamoto; Kazuya Takeda; Suguru Dobashi; Haruna Ohashi; Ken Takeda; Keiichi Jingu
Journal:  Radiat Oncol       Date:  2021-04-30       Impact factor: 3.481

10.  Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study.

Authors:  Adrian Kobe; Juliana Zgraggen; Florian Messmer; Gilbert Puippe; Thomas Sartoretti; Hatem Alkadhi; Thomas Pfammatter; Manoj Mannil
Journal:  Eur J Radiol Open       Date:  2021-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.